SORRENTO THERAPEUTICS, INC., IssuerIndenture • March 13th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 13th, 2020 Company Industry JurisdictionINDENTURE, dated as of , 20 , by and between Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):